Prognostic value and potential mechanism of the six-transmembrane epithelial antigen of the prostate family in clear cell renal cell carcinoma

Prognostic value and potential mechanism of the six-transmembrane epithelial antigen of the prostate family in clear cell renal cell carcinoma

Bibliographic Details
Main Authors:	Haotian Wei, Jian Zhang, Dadong Wei
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Asian Journal of Surgery
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423009612

Similar Items

Six‐transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial–mesenchymal
by: Haotian Wei, et al.
Published: (2023-08-01)

Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma
by: Ju MH, et al.
Published: (2023-04-01)

Six Transmembrane Epithelial Antigen 1 as a Prognostic Biomarker in Carcinomas: A Meta-Analysis
by: Shidi Zhao, et al.
Published: (2023-11-01)

Overall landscape and prognostic value of the splicing factor 3 complex in clear-cell renal cell carcinoma
by: Jian Zhang, et al.
Published: (2023-12-01)

Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis
by: Ting Ding, et al.
Published: (2023-01-01)

Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2
by: Kehan Chen, et al.
Published: (2023-11-01)

STEAP1–4 (Six-Transmembrane Epithelial Antigen of the Prostate 1–4) and Their Clinical Implications for Prostate Cancer
by: Michael Xu, et al.
Published: (2022-08-01)

Six-transmembrane epithelial antigen of the prostate (STEAP1 and STEAP2)-differentially expressed by murine and human mesenchymal stem cells.
by: Vaghjiani, R, et al.
Published: (2009)

Specific Six-Transmembrane Epithelial Antigen of the Prostate 1 Capture with Gellan Gum Microspheres: Design, Optimization and Integration
by: João Batista-Silva, et al.
Published: (2023-01-01)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
by: Chaston Weaver, et al.
Published: (2022-11-01)

Prognostic and Immune Infiltration Signatures of GIMAP Family Genes in Clear Cell Renal Cell Carcinoma
by: Mengjiao Zhang, et al.
Published: (2023-11-01)

FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma
by: Hui Gou, et al.
Published: (2023-09-01)

High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma
by: Langmei Deng, et al.
Published: (2023-03-01)

In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma
by: Revati Sharma, et al.
Published: (2023-05-01)

Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma
by: Anne Laure Giraudet, et al.
Published: (2023-07-01)

Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma
by: Fiorella L. Roldán, et al.
Published: (2022-08-01)

Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma
by: Shao-An Chen PhD, et al.
Published: (2023-12-01)

The prognostic value of CA9 expression in clear cell renal cell carcinoma
by: XU Jiankun, ZHOU Luting, ZHANG Wenjing, XU Haimin, WANG Chaofu
Published: (2023-02-01)

Murine double minute 2 aggravates adipose tissue dysfunction through ubiquitin-mediated six-transmembrane epithelial antigen of prostate 4 degradation
by: Wei Zhao, et al.
Published: (2022-07-01)

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
by: Can Chen, et al.
Published: (2024-02-01)

Emerging Targets in Clear Cell Renal Cell Carcinoma
by: Yu-Wei Chen, et al.
Published: (2022-10-01)

Comprehensive analysis of LAMC1 expression and prognostic value in kidney renal papillary cell carcinoma and clear cell carcinoma
by: Jianrong Bai, et al.
Published: (2022-09-01)

The prognostic significance of TRUB1 in patients with renal clear cell carcinoma
by: Qing-xin Yu
Published: (2024-02-01)

Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy
by: Kalle E. Mattila, et al.
Published: (2022-01-01)

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma
by: Xinyu Zhai, et al.
Published: (2023-10-01)

Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma
by: Rong Li, et al.
Published: (2023-07-01)

EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma
by: Luis Palomero, et al.
Published: (2020-01-01)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
by: Kai Gan, et al.
Published: (2022-10-01)

Zeta-crystallin serves as a prognostic biomarker for patients with kidney renal clear cell carcinoma
by: Xu Shi, et al.
Published: (2023-07-01)

A novel prognostic model based on six methylation-driven genes predicts overall survival for patients with clear cell renal cell carcinoma
by: Hongmin Zhou, et al.
Published: (2022-10-01)

Renal-Type Clear Cell Carcinoma of the Prostate: A Rare Case Report
by: Jamshid Ansari, et al.
Published: (2022-12-01)

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
by: Ming Sun, et al.
Published: (2022-10-01)

Bioinformatics-driven identification of prognostic biomarkers in kidney renal clear cell carcinoma
by: Varinder Madhav Verma, et al.
Published: (2024-04-01)

Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma
by: Kai Wei, et al.
Published: (2023-12-01)

Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration
by: Qianwei Xing, et al.
Published: (2022-06-01)

Identification of ALDOB as a novel prognostic biomarker in kidney clear cell renal cell carcinoma
by: Xiao-yang Li, et al.
Published: (2024-04-01)

Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
by: Gorka Larrinaga, et al.
Published: (2021-02-01)

Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
by: Na Li, et al.
Published: (2021-08-01)

KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma
by: Ke-Hao Pan, et al.
Published: (2023-09-01)

Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma
by: Fiorella L. Roldán, et al.
Published: (2021-12-01)